International Stem Cell Corporation (ISCO)

OTCMKTS: ISCO · Delayed Price · USD
0.103
0.00 (0.00%)
Mar 27, 2024, 10:48 AM EDT - Market closed
Market Cap 821.65K
Revenue (ttm) 8.33M
Net Income (ttm) 240,000
Shares Out 8.00M
EPS (ttm) 0.03
PE Ratio 3.42
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 21
Open 0.103
Previous Close 0.103
Day's Range 0.103 - 0.103
52-Week Range 0.050 - 0.220
Beta 0.47
Analysts n/a
Price Target n/a
Earnings Date n/a

About ISCO

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury. The company also offers anti-aging skin care products, including ProPlus Advanced Defense Complex, ProPlus Advanced Recovery Complex, ProPlus Eye Firmin... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 29
Stock Exchange OTCMKTS
Ticker Symbol ISCO
Full Company Profile

Financial Performance

In 2022, ISCO's revenue was $8.18 million, an increase of 13.99% compared to the previous year's $7.18 million. Losses were -$466,000, -55.19% less than in 2021.

Financial Statements

News

Eighteenth edition of Fujio Cup Quiz won by Kasturba Medical College, India in the NCRM NICHE 2023 international stem cell meeting.

TOKYO--(BUSINESS WIRE)--Kasturba medical college, XVIII Fujio cup quiz winners along with finalists become FCQ elites, an eligibility to nominate Edogawa NICHE Prize awardees.

5 months ago - Business Wire

International Stem Cell Corporation Announces Strong Financial Results for the Quarter Ended March 31, 2022

SAN DIEGO, CA / ACCESSWIRE / May 17, 2022 / International Stem Cell Corporation (OTC PINK:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnolo...

2 years ago - Accesswire